Extracerebral decarboxylase inhibitor is an inhibitory enzyme. It is used to inhibit the decarboxylation of L-DOPA to Dopamine outside the brain, i.e. in the blood. This is primarily co-administered with L-DOPA to combat Parkinsons Disease. Administration can prevent common side-effects, such as nausea and vomiting, as a result of interaction with D2 receptors in the vomiting center (or cheomoreceptor trigger zone) located outside the blood–brain barrier.
Examples of extracerebral decarboxylase inhibitors include Carbidopa and Benserazide.
References
Extracerebral decarboxylase inhibitor Wikipedia(Text) CC BY-SA